Detalhe da pesquisa
1.
Improved inflammatory activity with peginterferon alfa-2b maintenance therapy in non-cirrhotic prior non-responders: a randomized study.
J Hepatol
; 58(3): 452-9, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23159770
2.
Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial.
Lancet
; 376(9742): 705-16, 2010 Aug 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-20692693
3.
Early Detection of Steatohepatitis: Less Teeth NASHing and More Research?
Dig Dis Sci
; 61(7): 1788-9, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27250982
4.
A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update.
Clin Gastroenterol Hepatol
; 6(12): 1315-41; quiz 1286, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18845489
5.
Treatment of established recurrent hepatitis C in liver-transplant recipients with pegylated interferon-alfa-2b and ribavirin therapy.
Transplantation
; 78(9): 1303-7, 2004 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15548967
6.
Resistance-associated amino acid variants associated with boceprevir plus pegylated interferon-α2b and ribavirin in patients with chronic hepatitis C in the SPRINT-1 trial.
Antivir Ther
; 18(3): 387-97, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23406826
7.
Diagnosing and treating hepatitis C virus infection.
Am J Manag Care
; 17 Suppl 4: S108-15, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21767067
8.
Emerging strategies for pegylated interferon combination therapy.
Nat Clin Pract Gastroenterol Hepatol
; 4 Suppl 1: S17-21, 2007 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17235281
9.
Chronic hepatitis B: a critical appraisal of current approaches to therapy.
Clin Gastroenterol Hepatol
; 4(2): 233-48, 2006 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16469685
10.
Prediction of sustained virological response in liver transplant recipients with recurrent hepatitis C virus following combination pegylated interferon alfa-2b and ribavirin therapy using tissue hepatitis C virus reverse transcriptase polymerase chain reaction testing.
Liver Transpl
; 10(5): 595-8, 2004 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15108250